Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2018-11Actual
Enrollment · participants152Actual
Source updated2024-08-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.